Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Vila Corcoles, Angel ^a   Bejarano Romero, Ferran ^a   Salsench, Elisabeth ^a   Ochoa Gondar, Olga ^a   de Diego, Cinta ^a   Gomez Bertomeu, Frederic ^b   Raga Luria, Xavier ^c   Cliville Guasch, Xavier ^c   Arija, Victoria ^a,d  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c Hospital Sant Pau i Santa Tecla   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; ANTIINFECTIVE AGENT; OFLOXACIN; OXACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; SPAIN; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; AGED; BLOOD; CLASSIFICATION; COMMUNICABLE DISEASE; DRUG EFFECT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PNEUMOCOCCAL INFECTION; SEROTYPING; SPUTUM;

AGED; AGED, 80 AND OVER; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BLOOD; CEFOTAXIME; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; OXACILLIN; PNEUMOCOCCAL INFECTIONS; SEROTYPING; SPAIN; SPUTUM; STREPTOCOCCUS PNEUMONIAE;

EID: 64849103765     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-36     Document Type: Article

References (25)

1. Aspa J Rajas O de Castro FR Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia Expert Opin Pharmacother 2008, 9(2):229-41. 10.1517/14656566.9.2.229 18201146
2. Metlay JP Antibacterial drug resistance: Implications for the treatment of patients with community-acquired pneumonia Infect Dis Clin North Am 2004, 18(4):777-90. 10.1016/j.idc.2004.07.003 15555824
3. García-Rey C Fenoll A Aguilar L Casal J Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain J Antimicrob Chemother 2004, 54:465-71. 10.1093/jac/dkh375 15269198
4. Tleyjeh IM Tlaygeh HM Hejal R Montori VM Baddour LM The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: A systematic review and meta-analysis Clin Infect Dis 2006, 42:788-97. 10.1086/500140 16477555
5. Pallares R Liñares J Vadillo M Cabellos C Manresa F Viladrich PF Martin R Gudiol F Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain N Engl J Med 1995, 333:474-80. 10.1056/NEJM199508243330802 7623879
6. Aspa J Rajas O Rodríguez de Castro F Blanquer J Zalacain R Fenoll A de Celis R Vargas A Rodríguez Salvanés F España PP Rello J Torres A Pneumococcal Pneumonia in Spain Study Group Drug-resistant pneumococcal pneumonia: Clinical relevance and related factors Clin Infect Dis 2004, 38:787-98. 10.1086/381886 14999620
7. Fenoll A Asensio G Jado A Berrón S Camacho MT Ortega M Casal J Antimicrobial susceptibility and pneumococcal serotypes J Antimicrob Chemother 2002, 50(suppl S2):13-19. 10.1093/jac/dkf509 12556429
8. Garau J Treatment of drug-resistant pneumococcal pneumonia Lancet Infect Dis 2002, 2(7):404-15. 10.1016/S1473-3099(02)00316-X 12127352
9. Neuman MI Kelley M Harper MB File TM Jr Camargo CA Jr EMNet Investigators Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia J Emerg Med 2007, 32(4):349-57. 2034392 17499686 10.1016/j.jemermed.2006.08.014
10. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement M100-S17 2007, 27:126-8.
11. Clavo-Sánchez AJ Girón-González JA López-Prieto D Canueto-Quintero J Sánchez-Porto A Vergara-Campos A Marin-Casanova P Córdoba-Doña JA Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study Clin Infect Dis 1997, 24(6):1052-9. 10.1086/513628 9195057
12. Fine MJ Auble TE Yealy DM Hanusa BH Weissfeld LA Singer DE Coley CM Marrie TJ Kapoor WN A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 1997, 336:243-50. 10.1056/ NEJM199701233360402 8995086
13. Fine MJ Smith MA Carson CA Meffe F Sankey SS Weissfeld LA Detsky AS Kapoor WN Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials Arch Intern Med 1994, 154:2666-77. 7993150
14. Vallès X Marcos A Pinart M Piñer R Marco F Mensa JM Torres A Hospitalized Community-Acquired Pneumonia due to Streptococcus pneumoniae. Has resistance to antibiotics decreased? Chest 2006, 130:800-806. 10.1378/chest.130.3.800 16963678
15. Karlowsky JA Thornsberry C Jones ME Evangelista AT Critchley IA Sahm DF Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in United States: Results from the TRUST Surveillance Program (1998-2002) Clin Infect Dis 2003, 36:963-70. 10.1086/374052 12684907
16. Falcó V Almirante B Jordano Q Calonge L del Valle O Pigrau C Planes AM Gavaldà J Pahissa A Influence of penicillin resistance on outcome in adults patients with invasive pneumococcal pneumonia: Is penicillin useful against intermediately resistant strains? J Antimicrob Chemother 2004, 54:481-8. 10.1093/jac/dkh338 15215226
17. Neralla S Meyer KC Drug treatment of pneumococcal pneumonia in the elderly Drugs Aging 2004, 21(13):851-64. 10.2165/ 00002512-200421130-00003 15493950
18. Fenoll A Giménez MJ Robledo O Aguilar L Tarragó D Granizo JJ Martín-Herrero JE Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae Eur J Clin Microbiol Infect Dis 2008, 27(1):75-80. 10.1007/s10096-007-0402-5 17943330
19. Riedel S Beekmann SE Heilmann KP Richter SS Garcia-de-Lomas J Ferech M Goosens H Doern GV Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae Eur J Clin Microbiol Infect Dis 2007, 26(7):485-90. 10.1007/s10096-007-0321-5 17551759
20. Campbell GD Jr Silberman R Drug-resistant Streptococcus pneumoniae Clin Infect Dis 1998, 6(5):1188-95. 10.1086/520286
21. Yu VL Baddour LM Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality Clin Infect Dis 2004, 39(7):1086-7. 10.1086/423812 15472872
22. Song JH Oh WS Kang CI Chung DR Peck KR Ko KS Yeom JS Kim CK Kim SW Chang HH Kim YS Jung SI Tong Z Wang Q Huang SG Liu JW Lalitha MK Tan BH Van PH Carlos CC So T Asian Network for Surveillance of Resistant Pathogens Study Group Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: A prospective study by the Asian network for surveillance of resistant pathogens Int J Antimicrob Agents 2008, 31(2):107-14. 10.1016/j.ijantimicag.2007.09.014 18162378
23. Mufson MA Chan G Stanek RJ Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started Am J Med Sci 2007, 333(3):161-7. 10.1097/MAJ.0b013e3180312cd5 17496734
24. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement CLSI document M100-S18 Wayne, PA: Clinical and Laboratory Standards Institute 2008
25. Pérez-Trallero E García de la Fuente C García-Rey C Baquero F Aguilar L Dal-Re R García-de-Lomas J Spanish Surveillance Group for Respiratory Pathogens Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain Antimicrob Agents Chemother 2005, 49:1965-72. 1087652 15855520 10.1128/AAC.49.5.1965-1972.2005